Timosaponin AIII inhibits gastric cancer growth by the promotion of programmed cell death via the activation of p300/acetyl-p53 and Akt/MEK/ERK signaling

Kaizhen Tang, Wairong Zhao, Jing Zhang, Guangyu Wang, Wenting Shi, Meiyan Yue, Yan Lin, Yanli Fu, Zhongyan Zhou

Open source

DOI: 10.3389/fphar.2026.1821689
Published: 2026-07-20
Container: Frontiers in Pharmacology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1821689,
  title = {Timosaponin AIII inhibits gastric cancer growth by the promotion of programmed cell death via the activation of p300/acetyl-p53 and Akt/MEK/ERK signaling},
  author = {Kaizhen Tang and Wairong Zhao and Jing Zhang and Guangyu Wang and Wenting Shi and Meiyan Yue and Yan Lin and Yanli Fu and Zhongyan Zhou},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1821689},
  url = {https://doi.org/10.3389/fphar.2026.1821689}
}

RIS

TY  - JOUR
TI  - Timosaponin AIII inhibits gastric cancer growth by the promotion of programmed cell death via the activation of p300/acetyl-p53 and Akt/MEK/ERK signaling
AU  - Kaizhen Tang
AU  - Wairong Zhao
AU  - Jing Zhang
AU  - Guangyu Wang
AU  - Wenting Shi
AU  - Meiyan Yue
AU  - Yan Lin
AU  - Yanli Fu
AU  - Zhongyan Zhou
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1821689
UR  - https://doi.org/10.3389/fphar.2026.1821689
ER  -

APA

Tang, K., Zhao, W., Zhang, J., Wang, G., Shi, W., Yue, M., Lin, Y., Fu, Y., & Zhou, Z. (2026). Timosaponin AIII inhibits gastric cancer growth by the promotion of programmed cell death via the activation of p300/acetyl-p53 and Akt/MEK/ERK signaling. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1821689

Source records

crossref · retrieved 2026-09-26T17:03:05.510Z